[yoast-breadcrumb]
Formats
First Report from Public-Private Partnership Shows Variability in How Clinical Trials Are Monitored
[yoast-breadcrumb]
New CTTI Recommendations Provide Path for More Efficient Clinical Trials Using Clinical Registries
[yoast-breadcrumb]
CTTI Project: Registry Trials
Newly released recommendations from the Clinical Trials Transformation Initiative (CTTI) have the potential to streamline clinical trials by using registry information. Registries are data collection tools typically used to better understand long-term trends in a specific population, such as patients with a particular disease or patients exposed to a certain treatment.
Download Press Release (194.86 KB)
Clinical Trials Transformation Initiative Releases New Recommendations to Improve Studies of Antibacterial Drugs for Children
[yoast-breadcrumb]
CTTI Project: ABDD Peds Trial
Challenges in conducting antibacterial drug trials for pediatric patients can delay the safe and effective use of treatments for this vulnerable group. CTTI’s new recommendations for making pediatric antibacterial trials more successful. These practical, evidence-based strategies can be applied by research sponsors, investigators, and site staff to improve the quality and efficiency of pediatric antibacterial trials or pediatric trials in other therapeutic areas.
Download Press Release (213.88 KB)
Clinical Trials Transformation Initiative Releases Recommendations to Enhance the Feasibility of Developing New Antibacterial Drugs
CTTI Project: ABDD Streamlining HABP/VABP
CTTI’s two new sets recommendations outline innovative approaches to designing clinical trials for HABP/VABP, including early enrollment strategies and the streamlined collection of safety data. CTTI convened multi-stakeholder teams to analyze the challenges associated with HABP/VABP trials and develop the proposed solutions. The feasibility of these new approaches will be tested in an upcoming pilot study, the findings of which are expected to help drive adoption of streamlined practices for antibacterial drug development across the clinical trial enterprise.
Download Press Release (73.95 KB)
CTTI Releases New Recommendations and Resources for Using Real-World Data to Plan Trial Eligibility Criteria and Recruit Participants
[yoast-breadcrumb]
CTTI Project: Real World Data
During a public webinar today, the Clinical Trials Transformation Initiative (CTTI) will release new recommendations and resources on how to use real-world data (RWD) to evaluate trial eligibility criteria and recruit potential research participants.
Download Press Release (417.83 KB)
CTTI Releases Recommendations for Engaging Patients and Sites in Mobile Clinical Trials
[yoast-breadcrumb]
CTTI Project: Preparing a Site
During a public webinar today, the Clinical Trials Transformation Initiative (CTTI) will release new recommendations and resources for engaging patients and research sites when planning and conducting mobile clinical trials. By doing so, sponsors, contract research organizations, and other stakeholders can maximize the opportunities of mobile technologies to advance the development of new medical products.
Download Press Release (486.5 KB)
CTTI and FDA Convene Workshop on Including Patient Perspectives in Clinical Trials
[yoast-breadcrumb]
CTTI Project: Patient Group Engagement
The Clinical Trials Transformation Initiative (CTTI) will convene a public workshop, “Enhancing the Incorporation of Patient Perspectives in Clinical Trials," in collaboration with the U.S. Food and Drug Administration (FDA) on Mon., March 18, from 9:00 a.m. to 5:00 p.m. at the Tommy Douglas Conference Center in Silver Spring, Md.
Download Press Release (262.53 KB)
CTTI to Support NIH Workgroup in Developing Evaluation Plan for Single IRB Policy
[yoast-breadcrumb]
CTTI Project: Single IRB
The National Institutes of Health (NIH) has selected the Clinical Trials Transformation Initiative (CTTI) to support a workgroup that will develop a comprehensive plan for assessing the NIH’s new single institutional review board (sIRB) policy. The policy, which became effective in January, requires U.S. sites participating in nonexempt multicenter human subjects research funded by the NIH to use a sIRB for ethical review, with the goal of improving the quality and efficiency of clinical research.
Download Press Release (128.03 KB)
Clinical Trials: Do Participants Feel Safe?
[yoast-breadcrumb]
CTTI Project: Patient Group Engagement
Potential participants in clinical trials may not have a clear understanding of the methods used by researchers to ensure the safety of investigational drugs they are given.
Download Press Release (121.37 KB)